Bank of America’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-58
Closed -$3K 7663
2015
Q1
$3K Sell
58
-3,862
-99% -$116K ﹤0.01% 6669
2014
Q4
$94K Sell
3,920
-5,346
-58% -$121K ﹤0.01% 5937
2014
Q3
$234K Buy
9,266
+7,867
+562% +$195K ﹤0.01% 5264
2014
Q2
$37K Sell
1,399
-419
-23% -$10.8K ﹤0.01% 6860
2014
Q1
$47K Sell
1,818
-5,013
-73% -$136K ﹤0.01% 6458
2013
Q4
$138K Buy
6,831
+4,570
+202% +$108K ﹤0.01% 5898
2013
Q3
$59K Sell
2,261
-5,374
-70% -$135K ﹤0.01% 6332
2013
Q2
$168K Buy
+7,635
New +$167K ﹤0.01% 5785

Bank of America's HPTX Position: Q2 2015 in Review

Bank of America sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 58 shares — an estimated $3K sold.

Bank of America first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $234K in Q3 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Bank of America reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Bank of America sold 58 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $3K.
  • Bank of America first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Bank of America's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $234K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Bank of America's 13F filing for Q2 2015, filed 14 Aug 2015.